• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 1
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue1

Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province.

    Hayfaa A. Thijail BSc Hind M. Mousa PhD

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 3537-3546

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

This study designed to compare the vital role of the inflammatory immune responses and autoimmunity in development both types of diabetic mellitus by measurement of serum IL-17 , and Anti-Gad levels among patients groups and healthy by using ELISA kits . The study included sixty DM patients were divided into two groups : 30 patients with Type I DM ( 33.7% ) , and 30 patients with Type II DM (33.7%) . In addition to 29 healthy individuals were (32.6 %) . The results indicated an elevated mean serum level of IL-17 and Anti-Gad in both patients groups , as compared with the healthy control with significant difference . Also, the findings recorded a highly significant difference in IL-17 and Anti-Gad sera levels between both types of patient groups at (P< 0. 01) . According to the correlation results between IL-17 and Anti-Gad in patients groups , the data was demonstrated that the expression of IL-17 had a significant positive correlation with expression of Anti-Gad (P< 0.05) among Type I patients . Whereas an inverse very weak correlation was observed between IL-17 and Anti-Gad with no significant (P ˃ 0.05) in Type 2 patients . we concluded the an elevated levels of IL-17A in both types of DM may be as a prognostic factor for development them in Iraqi population. We also conclude that elevated Anti-Gad in Type II DM may be an indication of the rapid development of undiagnosed insulin deficiency in latent autoimmune diabetes in adult patients .
Keywords:
    Diabetes mellitus IL-17 Anti-Gad-65 Auto-immune diseases
  • PDF (595 K)
  • XML
(2020). Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province.. European Journal of Molecular & Clinical Medicine, 7(1), 3537-3546.
Hayfaa A. Thijail BSc; Hind M. Mousa PhD. "Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province.". European Journal of Molecular & Clinical Medicine, 7, 1, 2020, 3537-3546.
(2020). 'Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province.', European Journal of Molecular & Clinical Medicine, 7(1), pp. 3537-3546.
Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province.. European Journal of Molecular & Clinical Medicine, 2020; 7(1): 3537-3546.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 53
  • PDF Download: 96
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus